Season 1 · Episode 21
S1 Ep21: 1-on-1 with David Johnson: Enveric's Endocannabinoid Products for Glioblastoma
April 12, 202116m 5s
Audio is streamed directly from the publisher (audioboom.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In this episode, CancerNetwork sat down for a conversation with David Johnson, chairman and CEO of Enveric Biosciences. Johnson gave a thorough background of the biosciences company, and detailed the endocannabinoid products Enveric is developing to positively impact the quality of life for patients with glioblastoma.
Don’t forget to subscribe to the "Oncology Peer Review On-The-Go" podcast anywhere podcasts are available.
Don’t forget to subscribe to the "Oncology Peer Review On-The-Go" podcast anywhere podcasts are available.